Search of new approaches for harmless, non-medication treatment of body dysfunctions is still on the agenda of vet and human practitioners and researchers as well. This study presents evaluation of the effect of “Stress Relief” dietary supplement (SR) on mice behaviour under different acute short-term stress conditions and treatment duration. Five experiments were performed and in each 40 animals were randomly split into four (I–IV) groups, where I and II — non-stressed mice, III and IV — stressed animals, I and III received water with trace mineral solution (TMS), II and IV received water with SR. As stress factors, forced swimming, rodent predator odour or both together were applied. Locomotor activity under normal and stress conditions in Open Field were observed and measured by a SMART video-tracking system. Blood glucose level was measured as well. SR showed a reversal of stress-decreased locomotor activity in all stress models — distance walked increased almost twice (p < 0.0001), central zone crossings and time spent in it were 2–4 times greater than in the control group (p < 0.0001 and p = 0.0002, respectively), and fast movement episodes and maximal speed increased by 50–200%. In addition, complete normalisation of stress-induced elevation of blood glucose level (p < 0.0001) was noted. These results demonstrate for the first time that the effect of “Stress Relief” formula (water additives–minerals processed by know-how way in Vital Force Technology using Dr. Yury Kronn method) can be observed in laboratory animals, and that the effects are significant and repeatable. SR shows fear- and stress-reducing activity, which does not sufficiently differ between 7-, 9-, 14-, 28- and 32-day treatment regimes.
Bao, A.-M., Meynen, G., Swaab, D. F. (2008). The stress system in depression and neurodegeneration: Focus on the human hypothalamus. Brain Res. Rev., 57, 531–553.
Berry, A., Bellisario, V., Capoccia, S., Tirassa, P., Calza, A., Alleva, E., Cirulli, F. (2012). Social deprivation stress is a triggering factor for the emergence of anxiety-and depression-like behaviours and leads to reduced brain BDNF levels in C57BL/6J mice. Psychoneuroendocrinology, 37, 762–772.
Bet, P. M., Hugtenburg, J. G., Penninx, B. W. J. H., van Balkom, A., Nolen, W. A., Hoogendijk, W. J. G. (2013). Treatment inadequacy in primary and specialized care patients with depressive and/or anxiety disorders. Psychiatry Res., 210, 594–600.
Bussey, T. J., Holmes, A., Lyon, L., Mar, A. C., McAllister, K. A., Nithianantharajah, J., Oomen, C. A., Saksida, L. M. (2012). New translational assays for preclinical modelling of cognition in schizophrenia: The touchscreen testing method for mice and rats. Neuropharmacology, 62, 1191–1203.
Commons, K. G., Cholanians, A. B., Babb, J. A., Ehlinger, D. G. (2017). The rodent forced swim test measures stress-coping strategy, not depression-like behavior. ACS Chem. Neurosci., 8 (5), 955–960.
Cryan, J. F., Holmes, A. (2005). The ascent of mouse: Advances in modelling human depression and anxiety. Nat. Rev. Drug Discov., 4, 775–790.
Forster, A. J., Murff, H. J., Peterson, J. F., Gandhi, T. K., Bates, D. W. (2003). The incidence and severity of adverse events affecting patients after discharge from the hospital. Ann. Intern. Med., 138 (3), 161–167.
Gerbarg, P. L., Brown, R. P. (2001). Phytomedicines for prevention and treatment of mental health disorders. Psych. Clin. North Amer., 36, 37–47.
Gerber, R. (2001). Vibrational Medicine. Bear & Company. 608 pp.
Gould, T. D., Dao, D. T.,, Kovacsics, C. E. (2009). The Open Field Test. In: Gould, T. D. (Ed.). Neuromethods V42, Mood and Anxiety Related Phenotypes in Mice. Humana Press. pp. 1–20.
Han, J., Yang, M., Chen, Y. (2011). Quantum: May be a new-found messenger in biological systems. BioScience Trends, 5 (3), 89–92.
Hefner, K., Holmes, A. (2007). Ontogeny of fear-, anxiety- and depression-related behaviour across adolescence in C57BL/6J mice. Behav. Brain Res., 176, 210–215.
Heredia, L., Torrente, M., Colomina, M. T., Domingo, J. L. (2014). Assessing anxiety in C57BL/6J mice: A pharmacological characterization of the open-field and light/dark tests. J. Pharmacol. Toxicol. Meth., 9, 108–114.
Jafari, Z., Kolb, B. E., Mohajerani, M. H. (2017). Effect of acute stress on auditory processing: A systematic review of human studies. Rev. Neurosci., 28 (1), 1–13.
Kemp, A. H., Gordon, E., Rush, A. J., Williams, L. M. (2008). Improving the prediction of treatment response in depression: Integration of clinical, cognitive, psychophysiological, neuroimaging, and genetic measures. CNS Spectrums, 13, 1066–1086.
Kim, Y. N., Cho, S.-H. (2014). A survey of complementary and alternative medicine practitioner’s perceptions of evidence-based medicine. Eur. J. Integr. Med.. 6 (2), 211–219.
Kronn, Y. (2003). Energy—the missing link to health. New effective energy medicine tools. Science of whole person healing. In: Proceedings of the First Interdisciplinary International Conference, 28–30 March 2003, Bethesda, Maryland. Rustom Roy (Ed.), iUniverse, Inc., Lincoln, NE, pp. 157–171.
Oschman, J. L. (2016). Energy Medicine: The Scientific Basis. Elsevier Science. 359 pp.
Qi, X., Lin, W., Li, J., Li, H., Wang, W., Wang, D., Sun, M. (2008). Fluoxetine increases the activity of the ERK-CREB signal system and alleviates the depressive-like behaviour in rats exposed to chronic forced swim stress. Neurobiol. Dis., 31, 278–285.
Rao, M. N., Slawecki, T. M., Hoover, M. R., Roy, R. (2008). Characterization and properties of structured waters. “Materials Day” at the Materials Research Institute, Penn State University, 15 April. Available from: http://www.personal.psu.edu/~tms9/water.html (accessed 4 August 2017).
Rindfleisch, J. A. (2010). Biofield Therapies: Energy Medicine and Primary Care. Primary Care: Clinics in Office Practice, 37, 165–179.
Ritchie, L., De Butte, M., Pappas, B. A. (2004). Chronic mild stress exacerbates the effects of permanent bilateral common carotid artery occlusion on CA1 neurons. Brain Res., 1014, 228–235.
Scholkmann, F., Fels, D., Cifra, M. (2013). Non-chemical and non-contact cell-to-cell communication: A short review. Amer. J. Transl. Res., 5 (6), 586–593.
Smith, D. G., Davis, R. J., Gehlert, D. R., Nomikos, G. G. (2006). Exposure to predator odour stress increases efflux of frontal cortex acetylcholine and monoamines in mice: Comparisons with immobilization stress and reversal by chlordiazepoxide. Brain Res., 1117, 24–30.
Sonnentag, S., Fritz, C. (2006). Endocrinological processes associated with job stress: Catecholamine and cortisol responses to acute and chronic stressors. In: Perrewe, P. L., Ganster, D. C. (Eds.). Research in Occupational Stress and Well-being. Elsevier, pp. 1–59.
Staples, L. G. (2010). Predator odour avoidance as a rodent model of anxiety: Learning-mediated consequences beyond the initial exposure. Neurobiol. Learning Memory, 94, 435–445.
Swanson, C. (2009). Life Force, the Scientific Basis: Breakthrough Physics of Energy Medicine, Healing, Chi and Quantum Consciousness. Poseidia Press. 720 pp.
van Reedt Dortland, A. K. B., Vreeburg, S. A., Giltay, E. J., Licht, C. M. M., Vogelzangs, N., van Veen, T., de Geus, E. J. C., Penninx, B. W. J. H., Zitman, F. G. (2013). The impact of stress systems and lifestyle on dyslipidemia and obesity in anxiety and depression. Psychoneuroendocrinology, 38, 209–218.
Wahner-Roedler, D. L., Lee, M. C., Chon, T. Y., Cha, S. S., Loehrer, L. L., Bauer, B. A. (2014). Physicians’ attitudes toward complementary and alternative medicine and their knowledge of specific therapies: 8-Year follow-up at an academic medical center. Complem. Ther. Clin. Practice, 20, 54–60.
Wallace, D. (2012). Examining fear and stress as mediators between disorder perceptions and personal health, depression, and anxiety. Soc. Science Res., 41, 1515–1528.
Wardle, J. L., Adams, J. (2014). Indirect and non-health risks associated with complementary and alternative medicine use: An integrative review. Eur. J. Integr. Med. 6 (4), 409–422.
Wilber, K. (2005). Toward a comprehensive theory of subtle energies. Explore, 1 (4), 252–270.
Young, J. W., Minassian, A., Paulus, M. P., Geyer, M. A. Perry, W. (2007). A reverse-translational approach to bipolar disorder: Rodent and human studies in the Behavioral Pattern Monitor. Neurosci. Biobehav. Rev., 31, 882–896.